Signal · Supplier & Corporate Risk
Jamjoom Pharma completes Pfizer facility acquisition in Saudi Arabia
What the source reported
Source-reported<p><img src="https://argaamplus.s3.amazonaws.com/169f02e8-3bab-451e-a491-c822e1c461bf.png" ></p> <p class="ckeCaption" >Logo ofJamjoom Pharma</p> <hr> <p >Jamjoom Pharmaceuticals Factory Co. (<a href="https://www.argaam.com/en/tadawul/tasi/jamjoom-pharma" target="_blank">Jamjoom Pharma</a>) completed on Aug. 16, its acquisition of a pharmaceutical manufacturing facility located in King Abdullah Economic City, Saudi Arabia, from Pfizer Saudi Limited, the company announced yesterday.</p> <p ></p> <p >The facility specializes in manufacturing and packaging oral solid dosage (OSD) medicines, covering the full production process and supported by fully integrated on-site quality control laboratories, and is now part of Jamjoom Pharma’s manufacturing network, according to a company statement.</p> <p ></p> <p >The company said the acquisition was completed following the signing of the facility’s sale and purchase agreement on April 26, 2026, and the fulfillment of customary conditions precedent, including obtaining the necessary regulatory approvals.</p>
- Publication
- Argaam - Company Disclosures · Stock Exchange/Regulatory Announcements
- Published
- 17th August 2026
- Original report
- argaam.com
ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.
What ProcIntel recorded
ProcIntel-derived- Category
- Supplier & Corporate Risk
- Geography
- Saudi Arabia, UAE
- Organisations
- None identified
- Collected
- 17th August 2026 · 14:37
Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Initial Significance Moderate (35.0/100). Strongest contributor: Procurement Impact (27.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (23.5/100, data sufficiency: Partial). Strongest contributor: Source Authority (12.0/40 points). Limiting factor: Corroboration (2.5/25 points).
- Strongest contributor
- Procurement Impact
- Limiting factor
- Geographic Breadth